tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit CalculatorCompound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ADCT Stock Latest News

ADC Therapeutics price target lowered to $8 from $9 at RBC Capital
The FlyADC Therapeutics price target lowered to $8 from $9 at RBC Capital
20d ago
ADCT
ADC Therapeutics withdrawing FY23 revenue guidance
The FlyADC Therapeutics withdrawing FY23 revenue guidance
20d ago
ADCT
ADC Therapeutics to Participate in September Investor Conferences
Press ReleasesADC Therapeutics to Participate in September Investor Conferences
27d ago
ADCT
ADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023)
Press ReleasesADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023)
1M ago
ADCT
ADC Therapeutics upgraded to Neutral from Underweight at JPMorgan
The FlyADC Therapeutics upgraded to Neutral from Underweight at JPMorgan
2M ago
ADCT
ADC Therapeutics reports Q2 adjusted EPS (37c), consensus (46c)
The FlyADC Therapeutics reports Q2 adjusted EPS (37c), consensus (46c)
2M ago
ADCT
ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
Press ReleasesADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
2M ago
ADCT
ADC Therapeutics to Host Second Quarter 2023 Financial Results Conference Call on August 8, 2023
Press ReleasesADC Therapeutics to Host Second Quarter 2023 Financial Results Conference Call on August 8, 2023
2M ago
ADCT
Overland ADCT BioPharma Announces NMPA Accepts Biologics License Application and Grants Priority Review for ZYNLONTA® for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Press ReleasesOverland ADCT BioPharma Announces NMPA Accepts Biologics License Application and Grants Priority Review for ZYNLONTA® for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
2M ago
ADCT
Overland ADCT BioPharma announces NMPA acceptance of BLA for ZYNLONTA
The FlyOverland ADCT BioPharma announces NMPA acceptance of BLA for ZYNLONTA
2M ago
ADCT
ADC Therapeutics to discontinue LOTIS-9 clinical trial
The FlyADC Therapeutics to discontinue LOTIS-9 clinical trial
2M ago
ADCT
ADC Therapeutics price target lowered to $2 from $5 at Morgan Stanley
The FlyADC Therapeutics price target lowered to $2 from $5 at Morgan Stanley
3M ago
ADCT
ADC Therapeutics announces pause of enrollment in Phase 2 LOTIS-9 trial
The FlyADC Therapeutics announces pause of enrollment in Phase 2 LOTIS-9 trial
3M ago
ADCT
ADC Therapeutics Announces Voluntary Pause of Enrollment in the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients
Press ReleasesADC Therapeutics Announces Voluntary Pause of Enrollment in the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients
3M ago
ADCT
ADC Therapeutics price target lowered to $12 from $20 at H.C. Wainwright
The FlyADC Therapeutics price target lowered to $12 from $20 at H.C. Wainwright
3M ago
ADCT
ADC Therapeutics Announces Evolution of Board of Directors
Press ReleasesADC Therapeutics Announces Evolution of Board of Directors
4M ago
ADCT
ADC Therapeutics appoints Robert Azelby to board of directors
The FlyADC Therapeutics appoints Robert Azelby to board of directors
4M ago
ADCT
ADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL
Press ReleasesADC Therapeutics Announces Updated LOTIS-2 Results Demonstrating Durable, Long-Term Responses of ZYNLONTA® in Relapsed/Refractory DLBCL
4M ago
ADCT
ADC Therapeutics to Participate in the Jefferies Healthcare Conference
Press ReleasesADC Therapeutics to Participate in the Jefferies Healthcare Conference
4M ago
ADCT
Buy/Sell: Wall Street’s top 10 stock calls this week
The FlyBuy/Sell: Wall Street’s top 10 stock calls this week
5M ago
ADCT
ATVI
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
5M ago
BR
CHK
ADC Therapeutics downgraded to Underperform at BofA on Zynlonta headwinds
The FlyADC Therapeutics downgraded to Underperform at BofA on Zynlonta headwinds
5M ago
ADCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >